CASP2 and cancer: This study provides a whole new perspective on the unanticipated role of caspase-2 as a negative regulator of ferroptosis, independent caspase-2 and/or its interacting proteins as a promising novel therapeutic strategy to promote the killing of mut-p53 cancer cells by ferroptosis.